| Trial ID: | L2110 |
| Source ID: | NCT01298882
|
| Associated Drug: |
Diacerein
|
| Title: |
Diacerein on Insulin Secretion in Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus|Overweight|Obesity
|
| Interventions: |
DRUG: Diacerein|OTHER: Placebo
|
| Outcome Measures: |
Primary: Fasting insulin concentration, 2 mo|Fasting glucose concentration, 2 mo|A1C concentration, 2 mo|First phase of insulin secretion, 2 mo|Late phase of insulin secretion, 2 mo|Total insulin secretion concentration, 2 mo |
|
| Sponsor/Collaborators: |
Sponsor: Coordinación de Investigación en Salud, Mexico | Collaborators: National Council of Science and Technology, Mexico
|
| Gender: |
ALL
|
| Age: |
ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: |Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT
|
| Start Date: |
|
| Completion Date: |
|
| Results First Posted: |
|
| Last Update Posted: |
2011-02-18
|
| Locations: |
Unidad de Investigación Médica en Epidemiología Clínica, Guadalajara, Jalisco, 44380, Mexico
|
| URL: |
https://clinicaltrials.gov/show/NCT01298882
|
